Characterization of the serological response to phospholipase D protein of Chlamydophila pneumoniae in patients with acute coronary syndromes

Microbes and Infection

Volumn 11, Issue 3, 2009, Pages 367-373

  Mancini, Fabiola ^a   Savarino, Andrea ^a   Losardo, Maria ^a   Cassone, Antonio ^a   Ciervo, Alessandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Atherosclerosis; Chlamydophila pneumoniae; ELISA; MIF; Phospholipase D; Synthetic peptides

Indexed keywords

ENZYME ANTIBODY; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; P5 PEPTIDE; PHOSPHOLIPASE D; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ANTIBODY TITER; ARTICLE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MICROIMMUNOFLUORESCENCE; PATHOGENESIS; PRIORITY JOURNAL; SEROLOGY; SERUM;

ACUTE CORONARY SYNDROME; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PHOSPHOLIPASE D;

CHLAMYDOPHILA PNEUMONIAE;

EID: 62649119601     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2008.12.015     Document Type: Article

References (35)

1. Grayston J.T., Campbell L.A., Kuo C.C., Mordhorst C.H., Saikku P., Thom D.H., and Wang S.P.A. New respiratory tract pathogen: Chlamydia pneumoniae strain Twar. J. Infect. Dis. 161 (1990) 618-625
2. Kuo C.C., Jackson L.A., Campbell L.A., and Grayston J.T. Chlamydia pneumoniae (Twar). Clin. Microbiol. Rev. 8 (1995) 451-461
3. Saikku P., Wang S.P., Kleemola M., Brander E., Rusanen E., and Grayston J.T. An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J. Infect. Dis. 151 (1985) 832-839
4. Miyashita N., Niki Y., Nakajima M., Fukano H., and Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adult. Chest 119 (2001) 1416-1419
5. Hahn D.L., Azenabor A.A., Beatty W.L., and Byrne G.I. Chlamydia pneumoniae as a respiratory pathogen. Front. Biosci. 7 (2002) e66-e76
6. Danesh J., Collins R., and Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet 350 (1997) 430-436
7. Gaydos C.A., and Quinn T.C. The role of Chlamydia pneumoniae in cardiovascular disease. Adv. Intern. Med. 45 (2000) 139-173
8. Hirono S., and Pierce G.N. Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis. Mol. Cell. Biochem. 246 (2003) 91-95
9. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
10. Gaona-Flores V., Garcia-Elorriaga G., Valerio-Minero M., Gonzalez-Veyrand E., Navarrete-Castro R., Palacios-Jimenez N., Del Rey-Pineda G., Gonzalez-Bonilla C., and Monasta L. Anti-Chlamydophila pneumoniae antibodies as associated factor for carotid atherosclerosis in patients with AIDS. Curr. HIV Res. 6 (2008) 267-271
11. Kauppinen M., and Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin. Infect. Dis. 21 Suppl. 3 (1995) S244-S252
12. Wang S. In: Allegra L., and Blasi F. (Eds). Chlamydia pneumoniae: the Lung and the Heart (1999), Springer-Verlag, Milano 16-23
13. Dowell S.F., Peeling R.W., Boman J., Carlone G.M., Fields B.S., Guarner J., Hammerschlag M.R., Jackson L.A., Kuo C.C., Maass M., Messmer T.O., Talkington D.F., Tondella M.L., and Zaki S.R. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin. Infect. Dis. 33 (2001) 492-503
14. Saikku P. In: Orfila J. (Ed). Chlamydial Infections. Proceedings of the 8th International Symposium on Human Chlamydial Infections (1994), Esculapio Press, Bologna 163-172
15. Molestina R.E., Klein J.B., Miller R.D., Pierce W.H., Ramirez J.A., and Summersgill J.T. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect. Immun. 70 (2002) 2976-2981
16. Alvesalo J., Greco D., Leinonen M., Raitila T., Vuorela P., and Auvinen P. Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy. J. Infect. Dis. 197 (2008) 156-162
17. Ciervo A., Visca P., Petrucca A., Biasucci L.M., Maseri A., and Cassone A. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin. Diagn. Lab. Immunol. 9 (2002) 66-74
18. Biasucci L.M., Liuzzo G., Ciervo A., Petrucca A., Piro M., Angiolillo D.J., Crea F., Cassone A., and Maseri A. Antibody response to chlamydial heat shock protein 60 strongly associated with acute coronary syndrome. Circulation 107 (2003) 3015-3017
19. Benagiano M., D'Elios M.M., Amedei A., Azzurri A., van der Zee R., Ciervo A., Rombola G., Romagnani S., Cassone A., and Del Prete G. Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. J. Immunol. 174 (2005) 6509-6517
20. Hardardóttir H., Grünfeld C., and Feingold K.R. Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5 (1994) 207-215
21. Lee H., Shi W., Tontonoz P., Wang S., Subbanagounder G., Hedrick C.C., Hama S., Borromeo C., Evans R.M., Berliner J.A., and Nagy L. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ. Res. 87 (2000) 516-521
22. Hatch G.M., and McClarty G. Phospholipid composition of purified Chlamydia trachomatis mimics that of the eukaryotic host cell. Infect. Immun. 66 (1998) 3727-3735
23. Schmiel D.H., and Miller V.L. Bacterial phospholipases and pathogenesis. Microbes Infect. 1 (1999) 1103-1111
24. Nelson D.E., Crane D.D., Taylor L.D., Dorward D.W., Goheen M.M., and Caldwell H.D. Inhibition of chlamydiae by primary alcohols correlates with the strain-specific complement of plasticity zone phospholipase D genes. Infect. Immun. 74 (2006) 73-80
25. Wylie J.L., Hatch G.M., and McClarty G. Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J. Bacteriol. 179 (1997) 7233-7242
26. Edwards J.L., Entz D.D., and Apicella M.A. Gonococcal phospholipase D modulates the expression and function of complement receptor 3 in primary cervical epithelial cells. Infect. Immun. 71 (2003) 6381-6391
27. McNamara P.J., Cuevas W.A., and Songer G.J. Toxic phospholipases D of Corynebacterium pseudotuberculosis, C. ulcerans and Arcanobacterium haemolyticum: cloning and sequence homology. Gene 156 (1995) 113-118
28. Wilderman P.J., Vasil A.I., Johnson Z., and Vasil M.L. Genetic and biochemical analyses of a eukaryotic-like phospholipase D of Pseudomonas aeruginosa suggest horizontal acquisition and a role for persistence in a chronic pulmonary infection model. Mol. Microbiol. 39 (2001) 291-303
29. Ciervo A., Mancini F., and Cassone A. Transcription, expression, localization and immunoreactivity of Chlamydophila pneumoniae phospholipase D protein. Microb. Pathog. 43 (2007) 96-105
30. Saha S., Bhasin M., and Raghava G.P.S. Bcipep: a database of B-cell epitopes. BMC Genomics 6 (2005) 79
31. Hall T.A. Bioedit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41 (1999) 95-98
32. Kalman S., Mitchell W., Marathe R., Lammel C., Fan J., Hyman R.W., Olinger L., Grimwood J., Davis R.W., and Stephens R.S. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21 (1999) 385-389
33. Hackstadt T., Scidmore M.A., and Rockey D.D. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4877-4881
34. Carabeo R.A., Mead D.J., and Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6771-6776
35. Savarino A., Pistello M., D'Ostilio D., Zabogli E., Taglia F., Mancini F., Ferro S., Matteucci D., De Luca L., Barreca M.L., Ciervo A., Chimirri A., Ciccozzi M., and Bendinelli M. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS. Retrovirology 4 (2007) 79